| Advisory BoardPartnerships in Clinical Trials 2010 Advisory Board
- Solomon Babani, Director, Outsourcing and Vendor Management, Celtic Pharma
- Deirdre BeVard, Vice President, Clinical Operations & Data Management, Endo Pharmaceuticals
- Larry Blankstein, Senior Director, Clinical Research, Genzyme
- Christina DiArcangelo, Associate Director, Clinical Contracts and Outsourcing, FibroGen
- David Fenske, Executive Director, Global Head of Oncology Outsourcing, Novartis Pharmaceuticals
- Elisabeth Freeman, Global Brand Manager, Clinical Development Services, Covance Inc
- Suzanne Gagnon, MD, Senior Vice President and Chief Medical Officer, ICON Clinical Research
- Frances Grote, Senior Director, Strategic Sourcing, Millennium Pharmaceuticals
- Cory Gutterman, Associate Director, Outsourcing, Global Pharma R&D, Abbott Pharmaceuticals
- Gary Laine Director, Clinical Sourcing, Contracting and Payments, Elan Pharmaceuticals
- Jon Lee, Vice President, Development Operations, Cerexa
- Randy Marchbanks, Vice president, Business Development, Americas, PPD, Inc
- Mac McElroy, Executive Director, Strategic Development, Americas, Chiltern
- Patricia Monteforte, Senior Vice President Clinical Development, INC Research
- David Reasner, Senior Vice President, Biostatistics, Data Management and Health Outcomes, Sepracor
- Redge Santos, Operations Project Leader, Pharma Development Operations Leadership, Hoffman-La Roche
- Samir Shah, Vice President Strategic Development, RPS, Inc
- Lauri Sirabella, Vice President, Clinical Strategic Business Development, ExecuPharm
- Doug Smith, Executive Director, Clinical Project Management, AstraZeneca
- Jessica Stehr, Senior Director, Clinical Development Program Management, Merck & Company
- Jay Turpen, Director, Clinical Strategic Sourcing, Eli Lilly & Company
- Steve Whittaker, Chief Operations Officer, Director of Project Management CV/Acute Care, Eli Lilly & Company
|
